SLC2A4 and myeloid sarcoma: Nijland et al. investigated the distribution of specific glucose transporters in brain tissue of MS patients and non-neurological controls, and found that glucose transporter 1 (GLUT1) and 4 (GLUT4) are increased in MS lesions [66].